NTN COMMUNICATIONS, INC. -- SCHEDULE 13G (320507)

Company

Ernexa Therapeutics Inc.

Filed

March 14, 2003

Accession Number

0000894579-03-000019

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →